ANGELINA SHERIDAN: Open Payments
NPI 1295124618 · ETOWAH, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,264 in 57 payments from 22 companies in 2025. Trend: 2023 $1,157 · 2024 $1,240 · 2025 $1,264
Food & beverage: $1,264
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $230 |
| Axsome Therapeutics, Inc. | 5 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $163 |
| ABBVIE INC. | 8 | $135 |
| Novo Nordisk Inc | 3 | $76 |
| Amgen Inc. | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Medtronic, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
Products named: Auvelity, Kerendia, FASENRA, VRAYLAR, AIRSUPRA, Ozempic, GVOKE HYPOPEN, XIFAXAN.
Industry payments across TN — which companies pay providers there.
